Forward Science, a leader in oral health innovation, is pleased to announce the launch of PerioStōm, an FDA-approved, non-medicated oral wound dressing powered by chitosan microspheres.
Designed to protect oral mucosa following iatrogenic procedures such as scaling and root planing (SRP), PerioStōm offers a breakthrough solution to advance patient care and improve outcomes.
“This is a once-in-a-lifetime product,” said Robert Whitman, CEO of Forward Science.
Our team has worked tirelessly over the past decade to develop this innovative product, and we are excited to offer clinicians a cost-effective solution that meets the highest quality standards.”
PerioStōm is formulated with chitosan microspheres, a biocompatible polymer known for its antimicrobial, anti-inflammatory, and anti-biofilm properties.
Chitosan has been shown to inhibit biofilm formation and combat periodontal pathogens such as Porphyromonas gingivalis, making it an ideal choice for post-SRP care.
The formula uses an advanced delivery system with a curved stainless steel tip the same diameter as a curette for precise application to the base of periodontal pockets.
“PerioStōm is going to revolutionize dentistry. I think you’ve heard it all before about new products, but this time it’s real,” said Dr. Brian Pikkula, Chief Scientific Officer at Forward Science. “We’ve had the longest development cycle from concept to market, and the clinical results speak for themselves. Our team is excited to bring PerioStōm to market.”
PerioStōm® delivers a sustained release of the therapeutic benefits of chitosan to provide long-lasting protection to the oral mucosa. This innovative system ensures smoother recovery, less discomfort, and improved outcomes for periodontal surgery patients.
“PerioStōm® represents a pivotal advancement in periodontal care,” said Ellen Myers, Executive Director of Clinical Affairs and Strategic Markets at Forward Science.
This product directly addresses a long-standing clinical need by enhancing standard periodontal treatment, supporting clinicians in delivering consistently superior clinical outcomes.
We are proud to bring to market a solution that embodies scientific innovation and improves clinician and patient satisfaction throughout the periodontal care continuum.”
Related topics:
